Trial Profile
Study Of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy With Raltitrexed-Cisplatin for Patients With Locally Advanced Nasopharyngeal Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Feb 2022
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Raltitrexed (Primary)
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- 04 Feb 2022 Status changed from recruiting to completed.
- 01 Oct 2015 New trial record